Seritage accelerates property sales, reducing costs and nearing asset balance sheet values. See here for SRG's stock's ...

Fisher Asset Management's 13F portfolio grew from ~$231B to ~$252B in Q2 2025. Click here to read more about the trades and ...

SELLAS Life Sciences is developing GPS as a WT1 immunotherapy, which is in Phase 3 for AML. Click here to read why SLS stock ...